ÂÜÀòÂÒÂ×

The Leadership Team at Sionna Therapeutics is responsible for strategic oversight and decision-making in the development of innovative small molecule therapies for cystic fibrosis. Comprising experts in medical, regulatory, financial, and research disciplines, the team collaborates to guide the company's vision, ensuring efficient operations, compliance with regulatory standards, and alignment of research and development efforts with corporate objectives. Their collective expertise drives the advancement of promising therapies from discovery through clinical development to market introduction.